Clinical Study of Venetoclax Combined With CACAG Regimen in the Treatment of Newly Diagnosed Acute Myeloid Leukemia
Status:
Recruiting
Trial end date:
2024-01-10
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of venetoclax combined with
CACAG regimen in the treatment of newly diagnosed acute myeloid leukemia.